Skip to main content

Find Clinical Trials

Home
Conditions
Mononegavirales Infections

Clinical trial condition

Mononegavirales Infections

Explore clinical trials studying Mononegavirales Infections. Study availability and eligibility vary by location and protocol.

536 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Mononegavirales Infections trial results

Completed

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

NCT00384462

Conditions: Female Urogenital Diseases and Pregnancy Complications, Infections, Mononegavirales Infections, +10 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Central Arkansas Pediatric Clinic, P.A. Benton, Arkansas, United States

The Children's Clinic of Jonesboro, P.A. Jonesboro, Arkansas, United States

Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States

View all 59 locations

View Trial Details

Completed

Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults

NCT00192465

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: SFBC International, Inc Miami, Florida, United States

View Trial Details

Completed

Rabies Immunization Concomitant With JEV in Children

NCT00703521

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

NCT00351923

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany

View all 20 locations

View Trial Details

Completed

Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524

NCT00192478

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Hospital General de Niños "Ricardo Gutierrez" Buenos Aires, Argentina

Hospital Interzonal General de Agudos "Dr. Diego Paroissien Buenos Aires, Argentina

Hospital Clinico Pontificia Universidad Catolica de Chile Santiago, Chile

View Trial Details

Completed

Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers

NCT00694460

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +21 more
Locations: Tropical Medicine, Mahidol University Bangkok, Thailand

View Trial Details

Completed

Prevention of RSV Infections in Bone Marrow Transplant Recipients

NCT00001903

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Non-Specific Effects of Standard Titre Measles Vaccination

NCT00168662

Conditions: Death, Infant Death, Infections, +8 more
Locations: Bandim Health Project Bissau, Apartado 861, Guinea-Bissau

View Trial Details

Completed

Prophylactic Antibiotics in Measles

NCT00168532

Conditions: Infections, Lung Diseases, Measles, +9 more
Locations: Bandim Health Project Bissau, Apartado 861, Guinea-Bissau

View Trial Details

Completed

Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus

NCT00496821

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Alnylam Pharmaceuticals Cambridge, Massachusetts, United States

View Trial Details